Sign in

CIK 0001175680

  • Non-accelerated filer
  • Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
Operating
EIN
753056237
Phone
+1 360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 4 Grant or award Chief Operating Officer acquired 19,384 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Option exercise Director acquired 250,000 shares (option exercise)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Exercise or conversion Chairman & CMO acquired 166,000 shares (option exercise)
  7. 4 Open-market sale Chief Financial Officer sold 711,801 shares at an average $6.23 ($4,437,557)
  8. 4/A Open-market sale Chief Financial Officer sold 1,104,799 shares at an average $5.27 ($5,827,032)
  9. 4 Open-market sale Chief Financial Officer sold 1,108,799 shares at an average $5.28 ($5,849,360)
  10. 4 Open-market buy Director bought 193,500 shares at $2.57 ($497,295)
  11. 4 Open-market buy GC and Corporate Secretary bought 10,000 shares at $2.50 ($25,000)
  12. 4 Open-market buy Director bought 120,000 shares at $2.49 ($298,308)
  13. 4 Grant or award Chief Scientific Officer acquired 200,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award GC and Corporate Secretary acquired 70,000 shares (grant or award)
  16. 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
  18. 4 Grant or award Chairman & CMO acquired 250,000 shares (grant or award)
  19. 4 Grant or award President & CEO acquired 500,000 shares (grant or award)
  20. 4 Gift Chairman & CMO gave 74,800 shares (gift)

Page 6 of 22 · 435 filings